Investigation of aromatase inhibitory activity of metal complexes of 8-hydroxyquinoline and uracil derivatives

References

• Brueggemeier RW Hackett JC Diaz-Cruz ES Aromatase inhibitors in the treatment of breast cancer Endocr Rev 2005 26 3 331 345 15814851
   PubMed Web of Science ®Google Scholar
• Martín-Millán M Castañeda S Estrogens, osteoarthritis and inflammation Joint Bone Spine 2013 80 4 368 373 23352515
   PubMed Web of Science ®Google Scholar
• Straub RH The complex role of estrogens in inflammation Endocr Rev 2007 28 5 521 574 17640948
   PubMed Web of Science ®Google Scholar
• Cutolo M Wilder RL Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases Rheum Dis Clin North Am 2000 26 4 825 839 11084946
   PubMed Web of Science ®Google Scholar
• Pettersson K Gustafsson JA Role of estrogen receptor beta in estrogen action Annu Rev Physiol 2001 63 1 165 192 11181953
   PubMed Web of Science ®Google Scholar
• Michet CJJr McKenna CH Elveback LR Kaslow RA Kurland LT Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979 Mayo Clin Proc 1985 60 2 105 113 3974288
   PubMed Web of Science ®Google Scholar
• Couse JF Korach KS Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999 20 3 358 417 10368776
   PubMed Web of Science ®Google Scholar
• Attar E Bulun SE Aromatase and other steroidogenic genes in endometriosis: translational aspects Hum Reprod Update 2006 12 1 49 56 16123052
   PubMed Web of Science ®Google Scholar
• Recanatini M Cavalli A Valenti P Nonsteroidal aromatase inhibitors: recent advances Med Res Rev 2002 22 3 282 304 11933021
   PubMed Web of Science ®Google Scholar
• Simpson ER Mahendroo MS Means GD Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis Endocr Rev 1994 15 3 342 355 8076586
   PubMed Web of Science ®Google Scholar
• Schweikert HU Milewich L Wilson JD Aromatization of androstenedione by cultured human fibroblasts J Clin Endocrinol Metab 1976 43 4 785 795 977721
   PubMed Web of Science ®Google Scholar
• Perel E Wilkins D Killinger DW The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue J Steroid Biochem 1980 13 1 89 94 7382486
   PubMedGoogle Scholar
• Miller WR Hawkins RA Forrest AP Significance of aromatase activity in human breast cancer Cancer Res 1982 42 Suppl 8 3365s 3368s 7083201
   PubMed Web of Science ®Google Scholar
• Richelson LS Wahner HW Melton LJ Riggs BL Relative contributions of aging and estrogen deficiency to postmenopausal bone loss N Engl J Med 1984 311 20 1273 1275 6493283
   PubMed Web of Science ®Google Scholar
• Osborne CK Steroid hormone receptors in breast cancer management Breast Cancer Res Treat 1998 51 3 227 238 10068081
   PubMed Web of Science ®Google Scholar
• Simpson E Rubin G Clyne C The role of local estrogen biosynthesis in males and females Trends Endocrinol Metab 2000 11 5 184 188 10856920
   PubMed Web of Science ®Google Scholar
• Yang S Fang Z Suzuki T Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase J Clin Endocrinol Metab 2002 87 5 2336 2345 11994385
   PubMed Web of Science ®Google Scholar
• Yamaki J Yamamoto T Okada H Aromatization of androstenedione by normal and neoplastic endometrium of the uterus J Steroid Biochem 1985 22 1 63 66 3974228
   PubMedGoogle Scholar
• Watanabe K Sasano H Harada N Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies Am J Pathol 1995 146 2 491 500 7856758
   PubMed Web of Science ®Google Scholar
• Löfgren L Wallberg B Wilking N Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids Med Oncol 2004 21 4 309 318 15579914
   PubMed Web of Science ®Google Scholar
• Sainsbury R The development of endocrine therapy for women with breast cancer Cancer Treat Rev 2013 39 5 507 517 23102614
   PubMed Web of Science ®Google Scholar
• Brueggemeier RW Li PK Chen HH Moh PP Katlic NE Biochemical and pharmacological development of steroidal inhibitors of aromatase J Steroid Biochem Mol Biol 1990 37 3 379 385 2257241
   PubMed Web of Science ®Google Scholar
• Graves PE Salhanick HA Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide Endocrinology 1979 105 1 52 57 446416
   PubMed Web of Science ®Google Scholar
• Vanden Bossche H Willemsens G Roels I R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis Biochem Pharmacol 1990 40 8 1707 1718 2242008
   PubMed Web of Science ®Google Scholar
• Mason JI Murry BA Olcott M Sheets JJ Imidazole antimycotics: inhibitors of steroid aromatase Biochem Pharmacol 1985 34 7 1087 1092 3921030
   PubMed Web of Science ®Google Scholar
• Steele RE Mellor LB Sawyer WK Wasvary JM Browne LJ In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A Steroids 1987 50 1–3 147 161 2973160
   PubMedGoogle Scholar
• Bhatnagar AS Häusler A Schieweck K Lang M Bowman R Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor J Steroid Biochem Mol Biol 1990 37 6 1021 1027 2149502
   PubMed Web of Science ®Google Scholar
• Albrecht M Fiege M Osetska O 8-Hydroxyquinolines in metallosupramolecular chemistry Coord Chem Rev 2008 252 8–9 812 824
   Web of Science ®Google Scholar
• Lescoat G Léonce S Pierré A Gouffier L Gaboriau F Antiproliferative and iron chelating efficiency of the new bis-8-hydroxyquinoline benzylamine chelator S1 in hepatocyte cultures Chem Biol Interact 2012 195 2 165 172 22197641
   PubMed Web of Science ®Google Scholar
• Prachayasittikul S Worachartcheewan A Pingaew R Metal complexes of uracil derivatives with cytotoxicity and superoxide scavenging activity Lett Drug Des Discov 2012 9 3 282 287
   Web of Science ®Google Scholar
• Ding WQ Lind SE Metal ionophores – an emerging class of anticancer drugs IUBMB Life 2009 61 11 1013 1018 19859983
   PubMed Web of Science ®Google Scholar
• Daniel KG Chen D Orlu S Cui QC Miller FR Dou QP Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells Breast Cancer Res 2005 7 6 R897 R908 16280039
   PubMed Web of Science ®Google Scholar
• Prachayasittikul V Prachayasittikul S Ruchirawat S Prachayasittikul V 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications Drug Des Devel Ther 2013 7 1157 1178
   PubMed Web of Science ®Google Scholar
• Zheng H Gal S Weiner LM Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition J Neurochem 2005 95 1 68 78 16181413
   PubMed Web of Science ®Google Scholar
• Zheng H Weiner LM Bar-Am O Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer’s, Parkinson’s, and other neurodegenerative diseases Bioorg Med Chem 2005 13 3 773 783 15653345
   PubMed Web of Science ®Google Scholar
• Pavlov A Takuchev N Georgieva N Drug design by regression analyses of newly synthesized derivatives of 8-quinolinol Biotechnology & Biotechnological Equipment 2012 26 1 164 169
   Web of Science ®Google Scholar
• Jeon JH Lee CH Lee HS Antimicrobial activities of 2-methyl-8-hydroxyquinoline and its derivatives against human intestinal bacteria Journal of the Korean Society for Applied Biological Chemistry 2009 52 2 202 205
   Google Scholar
• Ahmed SM Ismail DA Synthesis and biological activity of 8-hydroxyquinoline and 2-hydroxypyridine quaternary ammonium salts J Surfactants Deterg 2008 11 3 231 235
   Web of Science ®Google Scholar
• Srisung S Suksrichavalit T Prachayasittikul S Ruchirawat S Prachayasittikul V Antimicrobial activity of 8-hydroxyquinoline and transition metal complexes International Journal of Pharmacology 2013 9 2 170 175
   Web of Science ®Google Scholar
• Strobl JS Seibert CW Li Y Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent J Parasitol 2009 95 1 215 223 18837587
   PubMed Web of Science ®Google Scholar
• Scheibel LW Adler A Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5,6 by an aromatic ring Mol Pharmacol 1982 22 1 140 144 6811856
   PubMed Web of Science ®Google Scholar
• Madrid PB Sherrill J Liou AP Weisman JL Derisi JL Guy RK Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities Bioorg Med Chem Lett 2005 15 4 1015 1018 15686903
   PubMed Web of Science ®Google Scholar
• Kim YH Woo KJ Lim JH 8-Hydroxyquinoline inhibits iNOS expression and nitric oxide production by down-regulating LPS-induced activity of NF-kappaB and C/EBPbeta in Raw 264.7 cells Biochem Biophys Res Commun 2005 329 2 591 597 15737626
   PubMed Web of Science ®Google Scholar
• Yamato M Hashigaki K Yasumoto Y Synthesis and antitumor activity of tropolone derivatives. 6. Structure-activity relationships of antitumor-active tropolone and 8-hydroxyquinoline derivatives J Med Chem 1987 30 10 1897 1900 3116257
   PubMed Web of Science ®Google Scholar
• Álvarez P Marchal JA Boulaiz H 5-Fluorouracil derivatives: a patent review Expert Opin Ther Pat 2012 22 2 107 123 22329541
   PubMed Web of Science ®Google Scholar
• Marchal JA Boulaiz H Rodríguez-Serrano F 5-fluorouracil derivatives induce differentiation mediated by tubulin and HLA class I modulation Med Chem 2007 3 3 233 239 17504194
   PubMed Web of Science ®Google Scholar
• Adelstein DJ Li Y Adams GL An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 2003 21 1 92 98 12506176
   PubMed Web of Science ®Google Scholar
• Adelstein DJ Saxton JP Lavertu P Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy J Clin Oncol 2002 20 5 1405 1410 11870186
   PubMed Web of Science ®Google Scholar
• Moertel CG Childs DSJr Reitemeier RJ Colby MYJr Holbrook MA Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer Lancet 1969 294 7626 865 867 4186452
   PubMed Web of Science ®Google Scholar
• Seitz JF Milan C Giovannini M Fondation Française de Cancérologie Digestive Groupe Digestif de la Fédération Nationale des Centres de Lutte Contre le Cancer Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803) Gastroenterol Clin Biol 2000 24 2 201 210 French 12687962
   PubMedGoogle Scholar
• Saniger E Campos JM Entrena A Medium benzene-fused oxacycles with the 5-fluorouracil moiety: synthesis, antiproliferative activities and apoptosis induction in breast cancer cells Tetrahedron 2003 59 29 5457 5467
   Web of Science ®Google Scholar
• Espinosa A Marchal JA Aránega A Gallo MA Aiello S Campos J Antitumoural properties of benzannelated seven-membered 5-fluorouracil derivatives and related open analogues. Molecular markers for apoptosis and cell cycle dysregulation Farmaco 2005 60 2 91 97 15752467
   PubMedGoogle Scholar
• Saniger E Campos JM Entrena A Neighbouring-group participation as the key step in the reactivity of acyclic and cyclic salicyl-derived O,O-acetals with 5-fluorouracil. Antiproliferative activity, cell cycle dysregulation and apoptotic induction of new O,N-acetals against breast cancer cells Tetrahedron 2003 59 40 8017 8026
   Web of Science ®Google Scholar
• Mazzaferro S Bouchemal K Ponchel G Oral delivery of anticancer drugs II: the prodrug strategy Drug Discov Today 2013 18 1–2 93 98 22960308
   PubMed Web of Science ®Google Scholar
• Rafique S Idrees M Nasim A Akbar H Athar A Transition metal complexes as potential therapeutic agents Biotechnology and Molecular Biology Reviews 2010 5 2 38 45
   Google Scholar
• Jackson A Davis J Pither RJ Rodger A Hannon MJ Estrogen-derived steroidal metal complexes: agents for cellular delivery of metal centers to estrogen receptor-positive cells Inorg Chem 2001 40 16 3964 3973 11466055
   PubMed Web of Science ®Google Scholar
• Brow JM Pleatman CR Bierbach U Cytotoxic acridinylthiourea and its platinum conjugate produce enzyme-mediated DNA strand breaks Bioorg Med Chem Lett 2002 12 20 2953 2955 12270182
   PubMed Web of Science ®Google Scholar
• Hambley TW Developing new metal-based therapeutics: challenges and opportunities Dalton Trans 2007 43 4929 4937 17992277
   PubMed Web of Science ®Google Scholar
• Suksrichavalit T Prachayasittikul S Nantasenamat C Isarankura-Na-Ayudhya C Prachayasittikul V Copper complexes of pyridine derivatives with superoxide scavenging and antimicrobial activities Eur J Med Chem 2009 44 8 3259 3265 19375194
   PubMed Web of Science ®Google Scholar
• Suksrichavalit T Prachayasittikul S Piacham T Isarankura-Na-Ayudhya C Nantasenamat C Prachayasittikul V Copper complexes of nicotinic-aromatic carboxylic acids as superoxide dismutase mimetics Molecules 2008 13 12 3040 3056 19078847
   PubMed Web of Science ®Google Scholar
• Pingaew R Worachartcheewan A Prachayasittikul V Prachayasittikul S Ruchirawat S Prachayasittikul V Transition metal complexes of 8 aminoquinoline-5-substituted uracils with antioxidative and cytotoxic a ctivities Lett Drug Des Discov 2013 10 9 859 864
   Web of Science ®Google Scholar
• Castonguay A Doucet C Juhas M Maysinger D New ruthenium(II)-letrozole complexes as anticancer therapeutics J Med Chem 2012 55 20 8799 8806 22991922
   PubMed Web of Science ®Google Scholar
• Mosmann T Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 1983 65 1–2 55 63 6606682
   PubMed Web of Science ®Google Scholar
• Carmichael J DeGraff WG Gazdar AF Minna JD Mitchell JB Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing Cancer Res 1987 47 4 936 942 3802100
   PubMed Web of Science ®Google Scholar
• Tominaga H Ishiyama M Ohseto F A water-soluble tetrazolium salt useful for colorimetric cell viability assay Analytical Communications 1999 36 2 47 50
   Web of Science ®Google Scholar
• Stresser DM Turner SD McNamara J A High-throughput screen to identify inhibitors of aromatase (CYP19) Anal Biochem 2000 284 2 427 430 10964434
   PubMed Web of Science ®Google Scholar
• Jemal A Siegel R Ward E Cancer statistics, 2008 CA Cancer J Clin 2008 58 2 71 96 18287387
   PubMed Web of Science ®Google Scholar
• Bulun SE Noble LS Takayama K Endocrine disorders associated with inappropriately high aromatase expression J Steroid Biochem Mol Biol 1997 61 3–6 133 139 9365182
   PubMed Web of Science ®Google Scholar
• Dowsett M Cuzick J Ingle J Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen J Clin Oncol 2010 28 3 509 518 19949017
   PubMed Web of Science ®Google Scholar
• Mouridsen H Gershanovich M Sun Y Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the international letrozole breast cancer group J Clin Oncol 2001 19 10 2596 2606 11352951
   PubMed Web of Science ®Google Scholar
• Paridaens RJ Dirix LY Beex LV Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group J Clin Oncol 2008 26 30 4883 4890 18794551
   PubMed Web of Science ®Google Scholar
• Shippen ER West WJJr Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor Fertil Steril 2004 81 5 1395 1398 15136110
   PubMed Web of Science ®Google Scholar
• Takayama K Zeitoun K Gunby RT Sasano H Carr BR Bulun SE Treatment of severe postmenopausal endometriosis with an aromatase inhibitor Fertil Steril 1998 69 4 709 713 9548162
   PubMed Web of Science ®Google Scholar
• Amsterdam LL Gentry W Jobanputra S Wolf M Rubin SD Bulun SE Anastrazole and oral contraceptives: a novel treatment for endometriosis Fertil Steril 2005 84 2 300 304 16084868
   PubMed Web of Science ®Google Scholar
• Brewer GJ Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson’s disease Exp Biol Med (Maywood) 2001 226 7 665 673 11444102
   PubMed Web of Science ®Google Scholar
• Theophanides T Anastassopoulou J Copper and carcinogenesis Crit Rev Oncol Hematol 2002 42 1 57 64 11923068
   PubMed Web of Science ®Google Scholar
• Daniel KG Harbach RH Guida WC Dou QP Copper storage diseases: Menkes, Wilsons, and cancer Front Biosci 2004 9 2652 2662 15358588
   PubMed Web of Science ®Google Scholar
• Nayak SB Bhat VR Upadhyay D Udupa SL Copper and ceruloplasmin status in serum of prostate and colon cancer patients Indian J Physiol Pharmacol 2003 47 1 108 110 12708132
   PubMedGoogle Scholar
• Huang YL Sheu JY Lin TH Association between oxidative stress and changes of trace elements in patients with breast cancer Clin Biochem 1999 32 2 131 136 10211630
   PubMed Web of Science ®Google Scholar
• Rizk SL Sky-Peck HH Comparison between concentrations of trace elements in normal and neoplastic human breast tissue Cancer Res 1984 44 11 5390 5394 6488192
   PubMed Web of Science ®Google Scholar
• Turecký L Kalina P Uhlíková E Námerová S Križko J Serum ceruloplasmin and copper levels in patients with primary brain tumors Klin Wochenschr 1984 62 4 187 189 6323815
   PubMedGoogle Scholar
• Chen D Cui QC Yang H Clioquinol, a therapeutic agent for Alzheimer’s disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts Cancer Res 2007 67 4 1636 1644 17308104
   PubMed Web of Science ®Google Scholar
• Bleackley MR Macgillivray RTA Transition metal homeostasis: from yeast to human disease Biometals 2011 24 5 785 809 21479832
   PubMed Web of Science ®Google Scholar
• Anjaneyulu Y Rao RP Swamy RY Eknath A Rao KN In vitro antimicrobial-activity studies on the mixed ligand complexes of Hg(II) with 8-hydroxyquinoline and salicylic acids Proceedings of the Indian Academy of Sciences – Chemical Sciences 1982 91 2 157 163
   Google Scholar
• Pollak Y Mechlovich D Amit T Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism J Neural Transm 2013 120 1 37 48 22446839
   PubMed Web of Science ®Google Scholar
• Crouch PJ Barnham KJ Therapeutic redistribution of metal ions to treat Alzheimer’s disease Acc Chem Res 2012 45 9 1604 1611 22747493
   PubMed Web of Science ®Google Scholar
• Cherny RA Atwood CS Xilinas ME Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer’s disease transgenic mice Neuron 2001 30 3 665 676 11430801
   PubMed Web of Science ®Google Scholar
• Bush AI Tanzi RE Therapeutics for Alzheimer’s disease based on the metal hypothesis Neurotherapeutics 2008 5 3 421 432 18625454
   PubMed Web of Science ®Google Scholar
• Malet-Martino M Martino R Clinical studies of three oral prodrugs of 5-fluorouracil (Capecitabine, UFT, S-1): a review Oncologist 2002 7 4 288 323 12185293
   PubMed Web of Science ®Google Scholar
• Ding WQ Liu B Vaught JL Yamauchi H Lind SE Anticancer activity of the antibiotic clioquinol Cancer Res 2005 65 8 3389 3395 15833873
   PubMed Web of Science ®Google Scholar
• Shaw AY Chang CY Hsu MY Synthesis and structure-activity relationship study of 8-hydroxyquinoline-derived Mannich bases as anticancer agents Eur J Med Chem 2010 45 7 2860 2867 20359788
   PubMed Web of Science ®Google Scholar